My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

41.59 -0.18 (-0.43%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Unusual volume stocks in Monday's session ↗

August 11, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Rigel (RIGL) Q2 Revenue Jumps 176% ↗

August 06, 2025

Via The Motley Fool

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Aligns Perfectly with Louis Navellier’s Growth Investing Strategy ↗

August 05, 2025

Louis Navellier’s growth investing strategy highlights stocks like RIGL with strong earnings momentum, rising sales, and profitability, making it a standout pick for investors.

Via Chartmill

What to Expect from Rigel Pharmaceuticals's Earnings ↗

August 04, 2025

Via Benzinga

Rockwell Automation Posts Better-Than-Expected Earnings, Joins Oscar Health, Charles River Laboratories, Walt Disney, Voya Financial And Other Big Stocks Moving Higher On Wednesday ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

A Preview Of Rigel Pharmaceuticals's Earnings ↗

May 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 06, 2025

Via Benzinga

Wall Street Awaits Trump's Tariff Decision, Digests Mixed Economic Data: What's Driving Markets Wednesday? ↗

March 05, 2025

The three major indices were mostly flat in midday trading Wednesday with the S&P 500 and Nasdaq slightly under the flatline and the Dow Jones up 39 points.

Via Benzinga

Topics Government Stocks

Rigel Pharmaceuticals: Q4 Earnings Insights ↗

March 05, 2024

Via Benzinga

Earnings Outlook For Rigel Pharmaceuticals ↗

March 04, 2024

Via Benzinga

Rigel Pharmaceuticals's Earnings: A Preview ↗

November 06, 2023

Via Benzinga

Stocks Drop As Trade War Escalates: What's Driving Markets Tuesday? ↗

March 04, 2025

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.

Via Benzinga

Topics World Trade

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 23, 2025

Via Benzinga

Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz ↗

January 14, 2025

The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.

Via Stocktwits

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

Dow Jumps Over 200 Points, Crude Oil Gains 1.5% ↗

December 24, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 08, 2024

Via Benzinga

Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®

October 16, 2024

From AscellaHealth, LLC

Via GlobeNewswire

RIGL Stock Earnings: Rigel Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

RIGL stock results show that Rigel Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues ↗

June 17, 2024

You don’t want to overlook these three penny stocks filled to the brim with the potential to make huge leaps in their respective markets.

Via InvestorPlace

RIGL Stock Earnings: Rigel Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 ↗

May 07, 2024

RIGL stock results show that Rigel Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 22, 2024

Via Benzinga

RIGL Stock Earnings: Rigel Pharmaceuticals Beats Revenue for Q4 2023 ↗

March 05, 2024

RIGL stock results show that Rigel Pharmaceuticals beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

February 28, 2024

Via AB Newswire

Earnings Scheduled For March 5, 2024 ↗

March 05, 2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 23, 2024

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.